Association between biomarkers of inflammation and dyslipidemia in drug resistant tuberculosis in Uganda
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Association between biomarkers of inflammation and dyslipidemia in drug resistant tuberculosis in Uganda ; volume:23 ; number:1 ; day:1 ; month:3 ; year:2024 ; pages:1-9 ; date:12.2024
Lipids in health and disease ; 23, Heft 1 (1.3.2024), 1-9, 12.2024
- Urheber
-
Baluku, Joseph Baruch
Nalwanga, Robinah
Kazibwe, Andrew
Olum, Ronald
Nuwagira, Edwin
Mugenyi, Nathan
Mulindwa, Frank
Bongomin, Felix
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12944-024-02063-7
- URN
-
urn:nbn:de:101:1-2405052126199.316395681754
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 07:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Baluku, Joseph Baruch
- Nalwanga, Robinah
- Kazibwe, Andrew
- Olum, Ronald
- Nuwagira, Edwin
- Mugenyi, Nathan
- Mulindwa, Frank
- Bongomin, Felix
- SpringerLink (Online service)
Ähnliche Objekte (12)
Predictors of treatment delay among drug resistant tuberculosis patients in Uganda
Cardiovascular risk factors among people with drug-resistant tuberculosis in Uganda
Multidrug-resistant tuberculosis
Low-cost rapid detection of rifampicin resistant tuberculosis using bacteriophage in Kampala, Uganda
Comparison of rapid tests for detection of rifampicin-resistant Mycobacterium tuberculosis in Kampala, Uganda
Epidemiological profile of patients with rifampicin-resistant tuberculosis: an analysis of the Uganda National Tuberculosis Reference Laboratory Surveillance Data, 2014–2018
Tuberculosis risk factors among tuberculosis patients in Kampala, Uganda: implications for tuberculosis control
The Mycobacterium tuberculosisUganda II family and resistance to first-line anti-tuberculosis drugs in Uganda
Diabetes Dyslipidemia
Nomogram to predict multidrug-resistant tuberculosis
Treatment of isoniazid-resistant pulmonary tuberculosis
Tuberculosis out of control : strategies to fight multidrug-resistant tuberculosis
Predictors of treatment delay among drug resistant tuberculosis patients in Uganda
Cardiovascular risk factors among people with drug-resistant tuberculosis in Uganda
Multidrug-resistant tuberculosis
Low-cost rapid detection of rifampicin resistant tuberculosis using bacteriophage in Kampala, Uganda
Comparison of rapid tests for detection of rifampicin-resistant Mycobacterium tuberculosis in Kampala, Uganda
Epidemiological profile of patients with rifampicin-resistant tuberculosis: an analysis of the Uganda National Tuberculosis Reference Laboratory Surveillance Data, 2014–2018
Tuberculosis risk factors among tuberculosis patients in Kampala, Uganda: implications for tuberculosis control
The Mycobacterium tuberculosisUganda II family and resistance to first-line anti-tuberculosis drugs in Uganda
Diabetes Dyslipidemia
Nomogram to predict multidrug-resistant tuberculosis
Treatment of isoniazid-resistant pulmonary tuberculosis
Tuberculosis out of control : strategies to fight multidrug-resistant tuberculosis
Predictors of treatment delay among drug resistant tuberculosis patients in Uganda
Cardiovascular risk factors among people with drug-resistant tuberculosis in Uganda
Multidrug-resistant tuberculosis
Low-cost rapid detection of rifampicin resistant tuberculosis using bacteriophage in Kampala, Uganda
Comparison of rapid tests for detection of rifampicin-resistant Mycobacterium tuberculosis in Kampala, Uganda
Epidemiological profile of patients with rifampicin-resistant tuberculosis: an analysis of the Uganda National Tuberculosis Reference Laboratory Surveillance Data, 2014–2018
Tuberculosis risk factors among tuberculosis patients in Kampala, Uganda: implications for tuberculosis control
The Mycobacterium tuberculosisUganda II family and resistance to first-line anti-tuberculosis drugs in Uganda
Diabetes Dyslipidemia
Nomogram to predict multidrug-resistant tuberculosis
Treatment of isoniazid-resistant pulmonary tuberculosis